CUSIP 92790C104COMVRDNQ4 2025
75 filings · latest Feb 17, 2026
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Fmr LLC | 14.38M | $447.64M |
| 2 | Blackrock, Inc. | 6.43M | $200.16M |
| 3 | Vanguard Group Inc | 5.61M | $174.65M |
| 4 | Bellevue Group AG | 4.36M | $135.64M |
| 5 | Fairmount Funds Management LLC | 3.91M | $121.82M |
| 6 | Vr Adviser, LLC | 3.88M | $120.83M |
| 7 | State Street Corp | 3.47M | $107.88M |
| 8 | Perceptive Advisors LLC | 3.04M | $94.69M |
| 9 | Deep Track Capital, LP |
| 4 | Oct 27, 2025 | Fairmount Funds Management LLC | 13D/A | 15.1% | — | SEC |
| 5 | May 15, 2025 | Kynam Capital Management, LP | 13G | 5.8% | 4.70M | SEC |
| 6 | Apr 11, 2025 | Commodore Capital LP | 13G | 5.3% | 4.30M | SEC |
| 7 | Feb 14, 2025 | Venrock Healthcare Capital Partners III, L.P. | 13G/A | 4.5% | 3.58M | SEC |
| 8 | Nov 14, 2024 | Perceptive Advisors LLC | 13G/A | 3.8% | 2.81M | SEC |
| 9 | Nov 14, 2024 | Venrock Opportunities Fund, L.P. | 13G/A | 2.9% | 1.88M | SEC |
| 10 | Nov 14, 2024 | Venrock Healthcare Capital Partners III, L.P. | 13G/A | 5.5% | 3.58M | SEC |
See the full Schedule 13D/13G history for Viridian Therapeutics Inc.
Unlock full history| 2.52M |
| $78.57M |
| 10 | Novo Holdings A/S | 2.38M | $74.07M |